ClinicalTrials.Veeva

Menu

Quality of Life Assessment of Children With Congenital Heart Disease Aged 5 to 7 Years (QoL-CHD-5-7)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Congenital Heart Disease

Treatments

Other: Quality of life questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT03931096
RECHMPL19_0061

Details and patient eligibility

About

Congenital heart diseases (CHD) are the firt cause of congenital malformations (8 for 1000 births). Since the 90's, great advances in prenatal diagnosis, pediatric cardiac surgery, intensive care, and cardiac catheterization have reduced morbidity and early mortality in this population. Prevalence of " GUCH ", grown-ups with congenital heart disease has thus been significantly increasing. Nowadays, quality of life (QoL) assessment of this population is in the foreground. Our team is a reference center in the management of patient with CHD, from the fetal period to adulthood. The investigators have been conducting a clinical research program on health related QoL in pediatric and congenital heart disease. The investigators thus demonstrated the link between cardiopulmonary fitness and QoL in children with CHD aged 8 to 18 years, the correlation between functional class and QoL in adults with CHD, and the impact of therapeutic education on QoL in children under anticoagulants. Currently, no controlled cross-sectional quality of life study assessment has been leaded in the youngest children with CHD. This present study therefore extends our work in younger children aged 5 to 7 years.

Full description

248 patients will be enrolled in this study.

Patient from groups 1 is included during his annual medical check-up. Quality of life questionnaire and other examinations are performed during this site visit. Its is a part of his usual care. No supplementary visit, directly related to the research, are necessary. 2 sites will participate to the enrollment, belonging to the French national network for complex congenital heart diseases (M3C) .

Participants (healthy children) from groups 2 are included from schools.The prior agreement of the Ministry of National Education was obtained before any procedure related to this study. 3 schools will participate to the enrolment

Enrollment

248 patients

Sex

All

Ages

5 to 7 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Children with CHD (as defined in the ACC-CHD classification) aged 5 to 7 years or same aged school children.

Exclusion criteria

  • Other comorbidity affecting quality of life (polymalformative syndrome, extracardiac organ failure, neurodegenerative disease, severe genetic disease, psychomotor retardation).
  • Surgical procedure during the last 6 months.
  • Inability to understand the QoL questionnaire (parents and / or child): non-french speaker, severe intellectual disability.

Trial design

248 participants in 2 patient groups

children with congenital heart disease
Description:
Groupe 1: case: children with congenital heart disease aged 5 to 7 years.
Treatment:
Other: Quality of life questionnaire
control children
Description:
Groupe 2: control children recruited in schools aged 5 to 7 years.
Treatment:
Other: Quality of life questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems